Clinical Hematology and Hemato-Oncology by Pati, Hara Prasad; Saxena, Renu; Bhattacharyya, Maitreyee; Dolai , Tuphan Kanti;

Long description:

This book focuses on the up-to-date advances in both clinical and lab hematology as well as hemato-oncology. It includes case-based discussions and algorithms of common hematological disorders both benign and malignant for easy diagnosis and treatment. It also discusses the applications of new-age diagnostic tools including flow cytometry, PCR-based diagnosis, and next-generation sequencing (NGS). From high-end lab technology to targeted therapies the book covers all the advancements including hemopoietic stem cell transplant. It is supplemented with ample illustrations, figures, and algorithms for diagnosis and management.

The book is relevant for postgraduate medical students in Internal medicine, pediatrics, pathology, D.M./DNB students of clinical and laboratory hematology, sub-specialty hematology practitioners, and postgraduate medical college teachers.

Table of Contents:

Chapter 1: Iron Metabolism and Inherited Causes of Iron Deficiency Anemia.- Chapter 2: Iron Deficiency Anemia: Newer Iron Formulations and Their Advantages.- Chapter 3: Non-Spherocytic Hemolytic Anemia – Diagnostic Approach.- Chapter 4: Management of Anemia of Renal Failure.- Chapter 5: Folate and Vitamin B12 Metabolism and Deficiency in Indian Population.- Chapter 6: Management of Aplastic Anemia.- Chapter 7: Comprehensive Management of Thalassemic Patients Including in Pregnancy.- Chapter 8: Comprehensive Management of Sickle Cell Disorders (SCD) Including in Pregnancy.- Chapter 9: Gene Therapy for Thalassemia/Hemoglobinopathy.- Chapter 10: Role of Flow Cytometry in Diagnosis of Benign Hematological Disorders.- Chapter 11: Molecular Genetic Tests in Thalassemia and Hemoglobinopathy: Pros and Cons of Different Techniques.- Chapter 12: Prenatal Diagnosis for Hereditary Hematologic Disorders.- Chapter 13: Next-Generation Sequencing (NGS) for Precision Medicine in Hematologic Disorders.- Chapter 14: Cytogenetics and Fluorescence In Situ Hybridization (FISH) in Hematologic Malignancies.- Chapter 15: Minimal Residual Disease (MRD) in Hematological Malignancies: Pros and Cons of Flow Cytometry, Molecular and NGS Techniques.- Chapter 16: Spectrum of Coagulation Factor Deficiency and Approach to Diagnosis.- Chapter 17: Newer Anticoagulants and Their Laboratory Monitoring.- Chapter 18: Management of Immune Thrombocytopenic Purpura (ITP): Including Approach in Refractory Patients in Children and Adults.- Chapter 19: Comprehensive Management of Hemophilia Including Recent Therapeutic Advances.- Chapter 20: Point of Care (POC) Equipment in Diagnosis and Management of Bleeding States.- Chapter 21: Advances in the Diagnosis of Disseminated Intravascular Coagulation (DIC) and Fibrinolysis.- Chapter 22: Thrombophilia: Their Relevance in Arterial and Venous Thrombosis.- Chapter 23: Diagnosis of Antiphospholipid Syndrome and Role in Different Clinical Conditions.- Chapter 24: Diagnosis of Thrombotic Thrombocytopenic Purpura (TTP) and Current Management.- Chapter 25: Next-Generation Sequencing (NGS) and Digital Polymerase Chain Reaction (PCR) as a Diagnostic Tool in Lymphoma by Liquid Biopsy.- Chapter 26: Flow Cytometric Diagnosis of Low-Grade Lymphoma.- Chapter 27: Risk Stratification and Advances in Chronic Lymphocytic Leukemia (CLL) Management: How to Choose the Best Bruton's Tyrosine Kinase (BTK) Inhibitor for CLL Patients?.- Chapter 28: Management of High-Grade Non-Hodgkin Lymphoma (NHL).- Chapter 29: Monoclonal Gammopathy of Undetermined Significance (MGUS) and Their Clinical Variants.- Chapter 30: Multiple Myeloma – A Curable Disease Now.- Chapter 31: World Health Organization (WHO) and International Consensus Classification (ICC) Classifications for Myeloid Neoplasms.- Chapter 32: Risk Stratification and Updates in Management of Myelodysplastic Syndromes (MDS).- Chapter 33: Management of Chronic Myelogenous Leukemia (CML) in Children and Adults.- Chapter 34: Diagnosis and Management of Non-BCR-ABL Myeloproliferative Neoplasms (MPN).- Chapter 35: Recent Advances in Management of Acute Myeloid Leukemia (AML).- Chapter 36: Management of Elderly Acute Myeloid Leukemia (AML).- Chapter 37: Venetoclax – A Magic Drug for Hematological Malignancies?.- Chapter 38: Chimeric Antigen Receptor T-Cell (CAR T Cell) Therapy in Hematologic Malignancies.- Chapter 39: Present Status of Stem Cell Transplantation (SCT) in Acute Leukemia in Children and Adults.- Chapter 40: Management of Acute and Chronic Graft-versus-Host Disease (GVHD), Current Status.- Chapter 41: Role of Stem Cell Transplantation (SCT) in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (ALL) in the Era of Second and Third Generation Tyrosine Kinase Inhibitors (TKI).- Chapter 42: Conditioning Regimens of Stem Cell Transplantation (SCT).- Chapter 43: Haploidentical Stem Cell Transplantation.- Chapter 44: Automated Hemogram Analyzer Parameters in Diagnosis of Sepsis/Infections.- Chapter 45: Blood Component Therapy in Hematological Patients.- Chapter 46: Management of Hemophagocytic Lymphohistiocytosis (HLH).